These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2989048)

  • 1. Towards the development of a new foot and mouth disease vaccine.
    Winther MD
    Dev Biol Stand; 1985; 59():73-7. PubMed ID: 2989048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering better vaccines for foot-and-mouth disease.
    Mason PW; Chinsangaram J; Moraes MP; Mayr GA; Grubman MJ
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past and present vaccine development strategies for the control of foot-and-mouth disease.
    Balamurugan V; Kumar RM; Suryanarayana VV
    Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches in viral vaccine development.
    Brown F
    Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus].
    Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM
    Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
    Sobrino F; Blanco E; García-Briones M; Ley V
    Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vaccine--a new approach to a safer foot-and-mouth disease virus vaccine.
    Pfaff E; Thiel HJ; Böhm HO; Leban J
    Arzneimittelforschung; 1987 Jan; 37(1):82-6. PubMed ID: 3032213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral immune response in cattle vaccinated against aphthovirus. Study of the kinetics of protective and neutralizing antibodies].
    Rojas GB; Rottenberg ME; Brunengo AM
    Rev Argent Microbiol; 1984; 16(4):195-208. PubMed ID: 6101040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.